Laboratory – Vitro master diagnóstica

Medical

Vitro S.A. sells Cytognos to BD to prioritize the market launch of their new and disruptive Molecular Biology and Anatomic Pathology diagnostic platforms

31 de January de 2022

Medical

The Vitro S.A. SARS-CoV-2 kits are able to detect and identify the Omicron variant.

20 de December de 2021

Chemistry Laboratory Scientific

Vitro S.A. launches a first-in-class SARS-CoV-2 antibody test with unprecedented performance, to be used as a confirmatory test for the vaccinated population

16 de February de 2021

Medical

Vitro releases a PCR platform that multiplies the current diagnostic capacity of COVID-19

1 de October de 2020

Chemistry Laboratory Scientific

Vitro releases a new in vitro diagnostic test for the simultaneous detection of the virus of the COVID-19 and other 20 respiratory pathogens

14 de July de 2020

Over 30 years of experience in developing and manufacturing reagents for immunohistochemistry, molecular diagnostic products, instruments and software.

info@vitro.bio

Vitro S.A. sells Cytognos to BD to prioritize the market launch of their new and disruptive Molecular Biology and Anatomic Pathology diagnostic platforms

The Vitro S.A. SARS-CoV-2 kits are able to detect and identify the Omicron variant.

Vitro S.A. launches a first-in-class SARS-CoV-2 antibody test with unprecedented performance, to be used as a confirmatory test for the vaccinated population

Vitro releases a PCR platform that multiplies the current diagnostic capacity of COVID-19

Vitro releases a new in vitro diagnostic test for the simultaneous detection of the virus of the COVID-19 and other 20 respiratory pathogens

Vitro S.A.

Anatomical pathology

Microbiology

Legal information